Cart

Dejan Matlak PostManager
An independent anthropologist with years of experience in academic writing and social science. His main field of interest is medical anthropology and the development of multidisciplinarian approaches for scientific research. He supports the furthering of science and critical thinking.
×
Dejan Matlak PostManager
An independent anthropologist with years of experience in academic writing and social science. His main field of interest is medical anthropology and the development of multidisciplinarian approaches for scientific research. He supports the furthering of science and critical thinking.
Latest Posts
  • Chronic rhinosinusitis
  • “Silent Killer”
  • Protein-Painting Technology
  • Computer Kidney
  • New research purposes that insomnia may be one of the drivers of suicidal thoughts in individuals with depression.
  • Suicide is becoming one of the major causes of death in the U.S. Furthermore, according to the National Institute of Mental Health suicide deaths rose in frequency by 31% from the year 2001-2007.
  • Researchers from this study recommend the use of sleeping pills for patients with depression and extreme insomnia.

About the Research

The study about insomnia and suicidal thoughts comes from the University of Wisconsin and Duke University. Furthermore, this is the first study that considers if targeting insomnia in depressive individuals decreases suicidal thoughts and actions. Even though the hypothesis is becoming well known in psychiatric research there are no clinical trials of this type that could prove it. Findings from this study are available through the Journal of American Psychiatry.

If you want to understand the current research behind insomnia and suicide, we recommend you look at this article.

Insomnia, Depression, and the Potential Treatment

Previous research on insomnia and depression explores the link between the two, but it does not address the issue of treatment. This is why this research is innovative as it offers a potential means for suicide prevention. Usually the practice is to give antidepressants to suicidal individuals but the researchers from this study explore a different option.

The study group for this research has 103 participants, their age is between 18 to 65 years. Out of the entire study group, 30% of the individuals had an attempt at suicide. Also, people with immediate suicide plans were not part of the research group.

Two drugs are part of this trial: Zolpidem-CR (an anti-insomnia drug) and an open-label selective serotonin reuptake inhibitor. Besides the two drugs, there was also a placebo group. Lastly, this was an eight-week drug trial.

The participants wrote daily self-reports, they wore a wrist device to remind them about the rest and activity cycles. Also, the psychiatric staff used the Beck Hopelessness Scale every time a participant in the trial came to them.

The results of the study show that both groups display symptoms of depression equally. However, the ant-insomnia medication group displays less suicidal tendencies. Such results confirm the main hypothesis of the research. Because of these findings, the scientists believe the anti-insomnia medication can become a part of suicide prevention plans.

Other recent research on mental health includes a study on refugees with PTSD and a look at the CRISPRi method for brain disease research.

Limitations

  • As this is an innovative approach to the issue, further research about insomnia and suicidal tendencies will come.